Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 214,010 | 190,553 | 158,702 | 181,657 | 213,752 |
| Marketable Securities | 79,526 | 73,290 | 72,296 | 68,916 | 36,194 |
| Receivables | 115,307 | 113,838 | 105,849 | 88,323 | 101,099 |
| Inventories | 228,819 | 177,928 | 154,875 | 132,412 | 118,782 |
| TOTAL | $676,173 | $594,066 | $538,007 | $510,799 | $504,736 |
| Non-Current Assets | |||||
| PPE Net | 27,108 | 27,759 | 28,570 | 28,718 | 29,383 |
| Intangibles | 211,712 | 212,540 | 213,367 | 214,186 | 214,995 |
| Other Non-Current Assets | 34,877 | 34,446 | 35,359 | 36,136 | 35,919 |
| TOTAL | $273,697 | $274,745 | $277,296 | $279,040 | $280,297 |
| Total Assets | $949,870 | $868,811 | $815,303 | $789,839 | $785,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28,630 | 19,103 | 13,893 | 14,451 | 12,947 |
| Accrued Expenses | 200,457 | 171,165 | 145,144 | 129,877 | 127,300 |
| TOTAL | $237,828 | $198,930 | $167,647 | $152,890 | $148,702 |
| Non-Current Liabilities | |||||
| Long Term Debt | 392,660 | 391,985 | 391,322 | 390,708 | 390,111 |
| Other Non-Current Liabilities | 45,141 | 47,472 | 52,030 | 52,683 | 52,175 |
| TOTAL | $437,801 | $439,457 | $443,352 | $443,391 | $442,286 |
| Total Liabilities | $675,629 | $638,387 | $610,999 | $596,281 | $590,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 314,001 | 308,534 | 308,239 | 307,931 | 300,116 |
| Common Shares | 3,037 | 3,017 | 3,016 | 3,016 | 2,944 |
| Retained earnings | -2,767,290 | -2,768,980 | -2,786,286 | -2,761,866 | -2,740,180 |
| Other shareholders' equity | 24,038 | 22,762 | 30,735 | 12,735 | 5,166 |
| TOTAL | $274,241 | $230,424 | $204,304 | $193,558 | $194,045 |
| Total Liabilities And Equity | $949,870 | $868,811 | $815,303 | $789,839 | $785,033 |